Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 3, Number 2—June 1997

Synopsis

Borna Disease

Carolyn G. Hatalski, Ann J. Lewis, and W. Ian LipkinComments to Author 
Author affiliations: University of California, Irvine, California, USA

Main Article

Table 2

Borna disease virus nucleic acid in patients with various diseases

Prevalence
Disease Tissue Disease (%) Controls (%) Divergence* Ref.
Psychiatric PBMC (4/6) 66.7 (0/10) 0 0-3.6 (22)
(various) PBMC (5/12) 41.7 (0/23) 0 0-4 (27)
PBMC (22/60) 37 (8/172) 4.7 (24, 25)
PBMC-coculture (3/32) 9.4 (0/5) 0 0.07-0.83 (23, 53)
Affective PBMC (1/3) 33.3 (0/23) 0 (27)
PBMC (1/6) 16.7 (0/36) 0 (51)
PBMC (0/9) 0 (56)
Schizophrenia PBMC (7/11) 63.6 (0/23) 0 (27)
PBMC (5/49) 10.2 (0/36) 0 (51)
PBMC 4.2-9.3 (54)
Brain (0/3) 0 (0/3) 0 (55)
CSF (0/48) 0 (0/9) 0 (55)
PBMC (0/9) 0 (0/9) 0 (55)
PBMC (0/26) 0 (56)
CFS PBMC (3/25) 12 6.0-14 (26)
Hippocampal sclerosis Brain (4/5) 80 (53)

Abbreviations: PBMC, peripheral blood mononuclear cells; CSF, cerebrospinal fluid; CFS, chronic fatigue syndrome.
*Divergence of P-gene nucleotide sequence from common BDV isolates (strain V [4] and He/80 [9]).

Main Article

TOP